News
Duchenne muscular dystrophy (DMD) is a muscle degeneration disorder caused by mutations affecting the dystrophin gene. Researchers show how a dual CRISPR RNA method restored dystrophin protein ...
The news: Myosana Therapeutics, a Seattle startup developing gene therapy technology, raised $5 million to develop an early-stage candidate treatment for Duchenne muscular dystrophy (DMD).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback